REGARD phase III, randon ed, double-blinded trial of mum ib and best supportive care (BSC) versus placebo and BSC in the Ireattneiti of metasta lie gastric or gastroesophageal junction (GEJ) adenocarcino u following disease progression on first-line platinum- and/or fluorop., midine-containing combination therapy.

被引：22

作者：

Fuchs, Charles S.

Tomasek, Jiri

Cho, Jae Yong

Dumitru, Filip

Passalacqua, Rodolfo

Goswami, Chanchal

Safran, Howard

dos Santos, Lucas Vieira

Aprile, Giuseppe

Ferry, David R.

Melichar, Bohuslav

Tehfe, Mustapha

Topuzov, Eldar

Tabemero, Josep

Zalcberg, John Raymond

Chau, Ian

Koshiji, Minori

Hsu, Yanzhi

Schwartz, Jonathan D.

Ajani, Jaffer A.

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Masaryk Univ, Fac Med, Masaryk Mem Canc Inst, Brno, Czech Republic

[3] Gangnam Severance Hosp, Seoul, South Korea

[4] Spitalul Judetean Urgenta Constantin Opris, Baia Mare, Romania

[5] Ist Ospitalieri Cremona, Cremona, Italy

[6] BP Poddar Hosp & Med Res Ltd, Kolkata, W Bengal, India

[7] Brown Univ, Sch Med, Providence, RI 02912 USA

[8] Barretos Canc Hosp, Barretos, Brazil

[9] Univ & Gen Hosp, Dept Oncol, Udine, Italy

[10] New Cross Hosp, Wolverhampton, England

[11] Fak Nemocnice Olomouc, Onkol Klin, Olomouc, Czech Republic

[12] CHUM, Notre Dame Hosp, Montreal, PQ, Canada

[13] Vail dHebron Univ Hosp, Vail dHebron Inst Oncol, Barcelona, Spain

[14] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[15] Univ Melbourne, Melbourne, Vic, Australia

[16] Royal Marsden Hosp, Sutton, Surrey, England

[17] ImClone Syst, Bridgewater, NJ USA

[18] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期

关键词：

D O I：

10.1200/jco.2013.31.4_suppl.lba5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA5

引用

页数：1